Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.09 |
mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.22 | 0.09 |
mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.083 | 0.09 |
mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.061 | 0.09 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.49 | 0.09 |
mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.077 | 0.09 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.084 | 0.09 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.077 | 0.09 |